Ectopic expression of PDLIM2 reverses the malignant phenotypes of lung cancer, and epigenetic agents, which can restore PDLIM2 expression, synergize with anti-PD-1 and notably with chemotherapeutic drugs for almost complete remission of lung cancer in the preclinical mouse model. Here, PDLIM2 is linked to lung carcinoma.